'TB vaccine discovery; where are we and where do we go from here?'
Seminar Wednesday 13:00 - 14:00
Professor Peter Andersen, Executive Vice President, Center for Vaccine Research, Statens Serum Institut, Copenhagen
Peter L. Andersen is Executive Vice President, Center for Vaccine Research at Statens Serum Institut. His research focus on the identification and characterisation of antigens, immune mechanisms and vaccine delivery systems that mediate protection against important pathogens such as Mycobacterium tuberculosis, Chlamydia trachomatis, Streptococcus pyogenes and Influenza. He has pioneered work on TB and Chlamydia vaccines, the CAF series of liposomal adjuvants and novel TB diagnostic assays and reagents. In his current position, he is responsible for the overall coordination of vaccine research and development covering activities from early research to clinical development. This program currently has two TB vaccines in late stage clinical testing and different liposomal adjuvant formulations and a novel Chlamydia trachomatis vaccine in phase 1 trials. The program also has a number of advanced novel and innovative vaccine modalities in late stage preclinical evaluation. In collaboration with industrial partners, his team has developed novel TB diagnostic tests (the IGRA assays) that are in widespread worldwide clinical use today and has recently completed a large-scale phase 3 testing of a novel specific skin test reagent to substitute for tuberculin.
Andersen has an extensive scientific production of more than 330 papers (H-index 76), over 20 patents and has given lectures all over the world. He was recognized by Thomson Scientific as the most cited researcher in Denmark within the field of immunology (1990 to 2005), and as one of the most cited researchers in the world within the diverse field of Tuberculosis (2009). Andersen heads several international research consortiums, has organized and chaired many international meetings, and received numerous large national and international research grants. He has received several prizes and awards and in 2011 he received the Novo Nordisk Prize; the most prestigious Danish award given as an acknowledgement for a lifetime scientific achievement. Andersen is a member of the Danish Research Council.
[Hosted by Associate Professor Thomas Scriba]
Wolfson Pavilion Lecture Theatre, IDM